Enzymaster raises $45m in Series C round
Biocatalysis expert Enzymaster (Germany, China, Singapore) has cashed in $45m to expand its production capacity of engineered biosynthetic enzymes.
ADVERTISEMENT
About Thomas Gabrielczyk
This author has not written his bio yet.
But we are proud to say that Thomas Gabrielczyk contributed 2153 entries already.
Entries by Thomas Gabrielczyk
EU starts consultation on novel plant breeding methods
The EU Commission has launched its final consultation on the deregulation of new breeding techniques in agriculture.
Evotec and BMS intensify R&D on protein degraders
Hamburg-headquartered Evotec SE has extended and expanded its three-year-old partnership with Bristol Myers Squibb in targeted protein degradation ("molecular glue degraders") for an additional eight years.
Bristol Myers Squibb brings in a huge library of E3 ligase modulators. Under the terms of the agreement, both parties will leverage all of Evotec’s appropriate platforms as well as AI/ML-based drug discovery.
Under the new agreement, Evotec cashes in an upfront payment of $200m and is eglible to obtain up to $5bn in milestone payments and tiered royalties on product sales.
New Laser Fluorescence Technique can deliver unique information in drug discovery
The optically pumped semiconductor laser (OPSL) is an ideal light source for structured illumination microscopy (SIM), a laser fluorescence technique that can deliver unique information in drug discovery.
Replacing beef with cellular protein halves deforestation
Replacing 20% of global beef consumption with fermentation-derived microbial protein by 2050 could halve annual deforestation and associated carbon dioxide emissions.
Hot of the press: BIOTECH Insight Newsletter
Deutsche Börse report key growth figures of the German biotech sector in 2021 in BIOTECH Insight, its new online information service published in collaboration with BIOCOM AG.
Engimmune Therapeutics raises CHF15.5m in seed financing
Cancer specialist Engimmune Therapeutics has raised CHF15.5m in a seed financing to expand its pipeline of T-cell receptor therapeutics.
Switzerland shows sustained growth of biotech sector
The Swiss Biotech sector has again attracted record-breaking investments in 2021, according to the Swiss Biotech Report that was presented at the Swiss Biotech Day 2022 in Basel.
Commission to establish EU health data space
Digital medicine holds great opportunities. The EU Commission is therefore presenting a draft law this week that defines rules for a European Health Data Space.
Increased Demand on HPAPIs Brings Renewed Focus on Product Development and Regulatory Requirements
The rapid growth of active pharmaceutical ingredients (APIs) has led to more biotech companies enlisting the support of strategic partners to navigate the regulatory environment and bring their innovative products to market.